News

The study enrolled subjects across the spectrum of deep venous disease, including those with post-thrombotic syndrome (PTS), non-thrombotic iliac vein lesions (NIVL), and those who presented with an acute deep vein thrombosis (aDVT).

Researchers at Beaumont Hospital, Royal Oak, have discovered a blood test for pregnant women that uses artificial intelligence and genetic-related biomarkers to accurately detect, fetal congenital heart defects, well before birth. 

Heart disease patients with symptomatic COVID-19 are often treated with nirmatrelvir-ritonavir (Paxlovid) to prevent progression to severe disease; however, it can interact with some previously prescribed medications. A review paper published...

"This document serves as a framework for hospitals and emergency departments looking to implement and expand their coronary CTA programs,” said Christopher Maroules, MD.

Project will develop robotic cardiovascular capabilities in rural America and study telerobotic treatment of heart attacks and strokes.

Daxor Corporation, focused on blood volume measurement technology, today announces new data from Duke Heart validating the benefits of the Company’s BVA-100 blood test in optimizing individualized therapy for heart failure patients.

In zebrafish and human cell cultures, oxytocin has yet another, unsuspected, function: it stimulates stem cells derived from the heart’s outer layer (epicardium) to migrate into its middle layer (myocardium) and there develop into...

“Neutrophils are key drivers of both arterial and venous thrombosis. And when you target a neutrophil, you do not increase bleeding risk, you only decrease clotting risk,” said Lalitha Nayak, MD.

The study shows that BVA, a diagnostic blood test, can help clinicians treat patients more effectively so that they get out of the hospital faster and have better mortality and readmission rates.